XML 145 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Operating activities      
Net income (loss) $ 966 $ (18,825) $ 53,820
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation 10,582 18,769 18,542
Provision for doubtful accounts 4,078 6,062 1,372
Stock-based compensation 5,414 8,993 7,543
Deferred income taxes 71 (545) (22,996)
Amortization of deferred financing costs and debt discount 293 512 682
Asset impairment charge 0 23,378 0
Equity in net loss (gain) of investees 29,685 6,072 (12,054)
Gain on sale of equity investment 0 0 (12,377)
Loss on sale of business 0 53,692 0
Gain on remeasurement of cost method investment 0 (6,577) 0
Deferred income taxes and income taxes receivable on sale of business 0 (51,861) 0
Other non-cash (credits) charges 0 (353) 296
Changes in operating assets and liabilities, net of effects of acquisitions:      
Accounts receivable and other receivables (29,928) (30,997) 5,715
Prepaid expenses and other 631 14,253 15,457
Self-funded insurance programs 809 (2,743) (5,731)
Accounts payable and accrued expenses (4,144) (21,799) (9,064)
Income taxes on gain from sale of business 30,822 0 0
Accrued transportation costs 2,175 1,301 11,232
Deferred revenue (1,298) (1,975) (4,691)
Other long-term liabilities 4,550 1,634 (629)
Net cash provided by operating activities 60,940 7,899 55,044
Investing activities      
Purchase of property and equipment (10,858) (17,521) (19,923)
Proceeds from sale of equity investment 0 0 15,593
Acquisitions, net of cash acquired 0 (43,711) 0
Dispositions or sale of business, net of cash sold 0 12,780 0
Cost method investments 0 0 (3,000)
Proceeds from note receivable 0 3,130 0
Other investing activities 0 0 310
Net cash used in investing activities (10,858) (45,322) (7,020)
Financing activities      
Preferred stock dividends (4,403) (4,413) (4,418)
Repurchase of common stock, for treasury (6,797) (56,088) (29,364)
Proceeds from common stock issued pursuant to stock option exercise 11,142 12,413 1,921
Proceeds from debt 12,000 42,000 0
Repayment of debt (12,000) (42,000) 0
Other financing activities (718) (3,467) (1,927)
Net cash used in financing activities (776) (51,555) (33,788)
Effect of exchange rate changes on cash 0 (261) 978
Net change in cash, cash equivalents and restricted cash 49,306 (89,239) 15,214
Cash, cash equivalents and restricted cash at beginning of period 12,367 101,606 86,392
Cash, cash equivalents and restricted cash at end of period 61,673 12,367 101,606
Supplemental cash flow information      
Cash included in current assets of discontinued operations held for sale 155 2,321 42,512
Cash paid for interest 1,261 1,162 987
Cash (received) paid for income taxes (30,037) 12,054 18,128
Proceeds receivable from option exercise 0 0 562
Purchases of equipment in accounts payable and accrued liabilities 0 0 1,362
Purchase of equipment through capital lease obligation 0 724 1,474
Acquisitions:      
Purchase price 0 54,700 0
Less:      
Cash acquired 0 (1,302) 0
Cash acquired 0 (110) 0
Value of existing ownership in Circulation 0 (9,577) 0
Acquisitions, net of cash acquired 0 43,711 0
Other Depreciation and Amortization $ 6,234 $ 8,908 $ 7,927